Skip to main content

Table 1 Differential Metabolites derived from OPLS-DA model of 1 H NMR analysis between rectal cancer patients and normal controls

From: ¹H NMR-based metabolic profiling of human rectal cancer tissue

Metabolites

chemical shift

Mutiplicitya

Rectal cancer vs. normal control

(ppm)

VIPb

P-valuec

FCd

1 Myo-inositol

4.06

t

4.32

<0.001

-2.00

 

3.55

dd

4.21

<0.001

-2.05

 

3.63

t

3.91

<0.001

-2.16

2 Taurine

3.27

t

4.25

<0.001

-2.10

3 α-Glucose

3.55

dd

4.21

<0.001

-2.05

 

5.23

dd

3.42

<0.001

-4.94

4 Phosphocreatine

3.93

s

3.56

<0.001

-2.13

 

3.04

s

3.30

<0.001

-2.11

5 Creatine

3.94

s

3.56

<0.001

-2.13

 

3.04

s

3.30

<0.001

-2.11

6 Betaine

3.89

s

2.70

<0.001

-1.89

7 Dimethylglycine

3.71

s

2.64

<0.001

-2.38

8 Glyceryl

4.3

m

2.51

<0.001

-1.45

9 Lactate

1.33

d

2.34

<0.001

1.24

 

4.11

q

1.55

<0.001

1.80

10 Threonine

1.33

d

2.34

<0.001

1.24

 

4.24

m

0.77

0.296

1.04

11 Acetate

1.93

s

2.27

0.004

2.97

12 Glutathione

2.56

m

2.19

<0.001

1.60

 

2.96

m

1.79

0.012

1.23

13 Uracil

7.54

d

2.16

<0.001

3.12

 

5.8

d

2.09

<0.001

3.27

14 Succinate

2.41

s

2.14

<0.001

1.84

15 O-acetyl glycoprotein

2.07

s

1.96

<0.001

1.77

16 Dimethylamine

2.73

s

1.94

0.029

1.28

17 Leucine

0.96

t

1.73

<0.001

1.17

18 Valine

1.05

d

1.72

0.166

1.48

 

0.99

d

1.66

0.016

1.36

19 β-hydroxybutyrate

1.2

d

1.69

<0.001

2.05

 

4.16

m

0.57

0.565

1.04

20 Formate

8.45

s

1.67

0.001

1.43

21 Glutamine

2.14

m

1.63

0.001

1.45

 

3.77

m

1.09

<0.001

1.35

22 Acetoacetate

2.28

s

1.55

0.008

1.21

23 Sarcosine

2.75

s

1.48

<0.001

1.02

24 Tyrosine

7.2

d

1.42

<0.001

-1.42

 

6.9

d

1.32

0.029

-1.30

25 Alanine

1.48

d

1.38

0.054

1.70

26 Acetoacetic acid

2.31

s

1.36

0.051

1.19

27 Serine

3.98

m

1.29

<0.001

1.45

28 Isoleucine

1.01

d

1.22

0.301

1.13

 

0.95

t

1.20

0.002

1.16

29 Methylamine

2.59

s

1.19

0.001

1.30

30 Trimethylamine-N-oxide

3.27

s

1.11

<0.001

2.96

31 Lysine

3.77

m

1.09

<0.001

1.35

32 Acetone

2.23

s

1.06

0.445

1.08

33 PC(phosphochline)

3.21

s

1.05

<0.001

1.22

  1. aMultiplicity: s singlet, d doublet, t triplet, q quartet, dd doublet of doublets, m multiplet.
  2. bVariable importance in the projection was obtained from OPLS-DA model with a threshold of 1.0.
  3. cp-value obtained from Student’s t-test.
  4. dFold change(FC) between rectal cancers and normal controls. Fold change with a positive value indicates a relatively higher concentration present in rectal cancer patients while a negative value means a relatively lower concentration as compared to the normal controls.